Foreign-Trade Zone 208 - New London, Connecticut, Expansion of Subzone and Manufacturing Authority-Subzone 208A, Pfizer Inc (Pharmaceutical Products), Groton, Connecticut, 43107 [E6-12228]
Download as PDF
Federal Register / Vol. 71, No. 146 / Monday, July 31, 2006 / Notices
Administrative Procedure Act/
Regulatory Flexibility Act.
Prior notice and an opportunity for
public comments are not required by the
Administrative Procedure Act or any
other law for rules concerning grants,
benefits, and contracts (5 U.S.C.
553(a)(2)). Because notice and
opportunity for comment are not
required pursuant to 5 U.S.C. 553 or any
other law, the analytical requirements of
the Regulatory Flexibility Act (5 U.S.C.
601 et seq.) are inapplicable. Therefore,
a regulatory flexibility analysis has not
been prepared.
Dated: July 25, 2006.
Benjamin Erulkar,
Deputy Assistant Secretary of Commerce, for
Economic Development and Chief Operating
Officer.
[FR Doc. E6–12250 Filed 7–28–06; 8:45 am]
BILLING CODE 3510–24–P
DEPARTMENT OF COMMERCE
Foreign–Trade Zones Board
[Docket 31–2006]
sroberts on PROD1PC70 with NOTICES
Foreign–Trade Zone 208 - New
London, Connecticut, Expansion of
Subzone and Manufacturing Authority–
Subzone 208A, Pfizer Inc
(Pharmaceutical Products), Groton,
Connecticut
An application has been submitted to
the Foreign–Trade Zones Board (the
Board) by the New London Foreign
Trade Zone Commission, grantee of FTZ
208, requesting to expand the subzone
and scope of manufacturing authority
under zone procedures for Subzone
208A, at the Pfizer Inc (Pfizer) facility in
Groton, Connecticut. It was formally
filed on July 20, 2006.
Subzone 208A was approved by the
Board in 2005 at Pfizer’s plant (61 bldgs.
on 57 acres/723,362 sq. ft., 195, 642 sq.
ft. of which is devoted to
manufacturing) located at 445 Eastern
Point Road, Groton, Connecticut. The
facility (400 employees) is used to
produce and/or distribute a wide range
of pharmaceuticals, with specific
authority granted for the manufacture of
a single product under zone procedures
(Board Order 1391, 5/9/05).
Pfizer is now requesting authority to
expand the subzone to include 2
additional parcels (31 bldgs. on 112
acres/3,480,165 sq. ft., approximately
one–third of which is devoted to
manufacturing) located at 38 Eastern
Road in Groton, adjacent to the current
site, for the manufacture of
pharmaceutical reference standards
(HTSUS 3822.00, duty–free). Reference
VerDate Aug<31>2005
17:34 Jul 28, 2006
Jkt 208001
standards not qualifying for entry under
HTSUS 3822.00 could qualify to be
entered under the prototype provision
of HTSUS 9817.85 (duty–free). Materials
sourced from abroad account for
approximately 20 percent of all
materials used in production. The
materials sourced from abroad primarily
consist of organic chemicals but, due to
the unique, wide–ranging nature of the
reference standards, they may also
include: animal by–products; corn
starch; gums, resins and other vegetable
saps and extracts; animal and vegetable
fats, oils and waxes; lactose and lactose
syrup; miscellaneous edible
preparations; ethyl alcohol; salts,
magnesium carbonate and talc; mineral
oils and products; inorganic chemicals
and compounds of precious metals;
pharmaceutical products; tannins,
pigments and acid dyes; essential oils;
sulfonates, surface active agents,
lubricating preparations and waxes; fish
glue, gelatin, peptones, dextrins and
enzymes; miscellaneous chemical
products; plastics; rubber and rubber
articles; paper and paperboard; printed
books; cotton wadding; glass products;
aluminum foil; base metals; optical,
medical and surgical instruments;
miscellaneous manufactured articles
(gelatin, wax and vegetable materials);
and chemicals (chapter 99). FTZ savings
will result initially from imported
materials used in the manufacture of
reference standards subject to duty rates
from duty–free to 7.5 percent.
The application also requests
authority to include a broad range of
inputs (listed above) for other finished
pharmaceutical products that Pfizer may
produce under FTZ procedures in the
future. (New major activity involving
these inputs/products would require
review by the FTZ Board.) The duty
rates for these inputs and final products
range from duty–free to 10 percent.
Zone procedures would exempt Pfizer
from Customs duty payments on foreign
materials used in production for export.
On domestic shipments, the company
would be able to defer Customs duty
payments on foreign materials, and to
choose the duty rate that applies to the
finished products instead of the rates
otherwise applicable to the foreign
input materials. Pfizer also expects to
realize additional savings through the
use of weekly entry procedures. The
application indicates that the savings
from zone procedures would help
improve the plant’s international
competitiveness.
In accordance with the Board’s
regulations, a member of the FTZ staff
has been designated examiner to
investigate the application and report to
the Board.
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
43107
Public comment is invited from
interested parties. Submissions (original
and 3 copies) shall be addressed to the
Board’s Executive Secretary at the
address listed below. The closing period
for their receipt is September 29, 2006.
Rebuttal comments in response to
material submitted during the forgoing
period may be submitted during the
subsequent 15-day period (to October
14, 2006).
A copy of the application and
accompanying exhibits will be available
for public inspection at each of the
following locations: the City of New
London’s Office of Development and
Planning, 111 Union Street, New
London, CT 06320; and, Office of the
Executive Secretary, Foreign–Trade
Zones Board, Room 1115, U.S.
Department of Commerce, 1401
Constitution Avenue, NW, Washington,
DC 20230.
Dated: July 20, 2006.
Andrew McGilvray,
Acting Executive Secretary.
[FR Doc. E6–12228 Filed 7–28–06; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF COMMERCE
International Trade Administration
A–570–893
Certain Frozen Warmwater Shrimp
from the People’s Republic of China:
Partial Rescission of the First
Administrative Review
Import Administration,
International Trade Administration,
Department of Commerce.
EFFECTIVE DATE: July 31, 2006.
FOR FURTHER INFORMATION CONTACT: P.
Lee Smith or Erin Begnal, AD/CVD
Operations, Office 9, Import
Administration, International Trade
Administration, U.S. Department of
Commerce, 14th Street and Constitution
Avenue, N.W., Washington D.C. 20230;
telephone: (202) 482–1655 and (202)
482–1442, respectively.
SUPPLEMENTARY INFORMATION:
AGENCY:
Background
On April 7, 2006, the Department
published in the Federal Register a
notice of initiation listing 163 firms for
which it received timely requests for an
administrative review of this
antidumping duty order. See Notice of
Initiation of Administrative Reviews of
the Antidumping Duty Orders on
Certain Frozen Warmwater Shrimp from
the Socialist Republic of Vietnam and
the People’s Republic of China, 71 FR
17813 (April 7, 2006) (‘‘Initiation
E:\FR\FM\31JYN1.SGM
31JYN1
Agencies
[Federal Register Volume 71, Number 146 (Monday, July 31, 2006)]
[Notices]
[Page 43107]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-12228]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[Docket 31-2006]
Foreign-Trade Zone 208 - New London, Connecticut, Expansion of
Subzone and Manufacturing Authority-Subzone 208A, Pfizer Inc
(Pharmaceutical Products), Groton, Connecticut
An application has been submitted to the Foreign-Trade Zones Board
(the Board) by the New London Foreign Trade Zone Commission, grantee of
FTZ 208, requesting to expand the subzone and scope of manufacturing
authority under zone procedures for Subzone 208A, at the Pfizer Inc
(Pfizer) facility in Groton, Connecticut. It was formally filed on July
20, 2006.
Subzone 208A was approved by the Board in 2005 at Pfizer's plant
(61 bldgs. on 57 acres/723,362 sq. ft., 195, 642 sq. ft. of which is
devoted to manufacturing) located at 445 Eastern Point Road, Groton,
Connecticut. The facility (400 employees) is used to produce and/or
distribute a wide range of pharmaceuticals, with specific authority
granted for the manufacture of a single product under zone procedures
(Board Order 1391, 5/9/05).
Pfizer is now requesting authority to expand the subzone to include
2 additional parcels (31 bldgs. on 112 acres/3,480,165 sq. ft.,
approximately one-third of which is devoted to manufacturing) located
at 38 Eastern Road in Groton, adjacent to the current site, for the
manufacture of pharmaceutical reference standards (HTSUS 3822.00, duty-
free). Reference standards not qualifying for entry under HTSUS 3822.00
could qualify to be entered under the prototype provision of HTSUS
9817.85 (duty-free). Materials sourced from abroad account for
approximately 20 percent of all materials used in production. The
materials sourced from abroad primarily consist of organic chemicals
but, due to the unique, wide-ranging nature of the reference standards,
they may also include: animal by-products; corn starch; gums, resins
and other vegetable saps and extracts; animal and vegetable fats, oils
and waxes; lactose and lactose syrup; miscellaneous edible
preparations; ethyl alcohol; salts, magnesium carbonate and talc;
mineral oils and products; inorganic chemicals and compounds of
precious metals; pharmaceutical products; tannins, pigments and acid
dyes; essential oils; sulfonates, surface active agents, lubricating
preparations and waxes; fish glue, gelatin, peptones, dextrins and
enzymes; miscellaneous chemical products; plastics; rubber and rubber
articles; paper and paperboard; printed books; cotton wadding; glass
products; aluminum foil; base metals; optical, medical and surgical
instruments; miscellaneous manufactured articles (gelatin, wax and
vegetable materials); and chemicals (chapter 99). FTZ savings will
result initially from imported materials used in the manufacture of
reference standards subject to duty rates from duty-free to 7.5
percent.
The application also requests authority to include a broad range of
inputs (listed above) for other finished pharmaceutical products that
Pfizer may produce under FTZ procedures in the future. (New major
activity involving these inputs/products would require review by the
FTZ Board.) The duty rates for these inputs and final products range
from duty-free to 10 percent.
Zone procedures would exempt Pfizer from Customs duty payments on
foreign materials used in production for export. On domestic shipments,
the company would be able to defer Customs duty payments on foreign
materials, and to choose the duty rate that applies to the finished
products instead of the rates otherwise applicable to the foreign input
materials. Pfizer also expects to realize additional savings through
the use of weekly entry procedures. The application indicates that the
savings from zone procedures would help improve the plant's
international competitiveness.
In accordance with the Board's regulations, a member of the FTZ
staff has been designated examiner to investigate the application and
report to the Board.
Public comment is invited from interested parties. Submissions
(original and 3 copies) shall be addressed to the Board's Executive
Secretary at the address listed below. The closing period for their
receipt is September 29, 2006. Rebuttal comments in response to
material submitted during the forgoing period may be submitted during
the subsequent 15-day period (to October 14, 2006).
A copy of the application and accompanying exhibits will be
available for public inspection at each of the following locations: the
City of New London's Office of Development and Planning, 111 Union
Street, New London, CT 06320; and, Office of the Executive Secretary,
Foreign-Trade Zones Board, Room 1115, U.S. Department of Commerce, 1401
Constitution Avenue, NW, Washington, DC 20230.
Dated: July 20, 2006.
Andrew McGilvray,
Acting Executive Secretary.
[FR Doc. E6-12228 Filed 7-28-06; 8:45 am]
BILLING CODE 3510-DS-S